List of works - Torben Biester

"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients

scientific article published on 18 January 2017

Add-on Therapy with Dapagliflozin under Full Closed Loop Control improves Time in Range in Adolescents and young Adults with Type 1 Diabetes- The DAPADream Study

scientific article published on 20 November 2020

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians

scientific article published on 18 July 2018

Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes

scientific article published on 01 April 2019

Blood pressure measurement methodology and technology in the SWEET diabetes centers: An international SWEET database survey

scientific article published on 09 September 2020

Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict metabolic control: A multicentre analysis of 15 199 adult type 1 diabetes patients from Germany and Austria

scientific article published on 19 May 2017

Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports

scientific article published on 11 June 2019

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial. ⬇️

scientific article

Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care

scientific article published on 01 June 2018

Comparison of pharmacokinetics and the exposure-response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

scientific article published on 20 June 2019

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

scientific article published in 2022

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabete

scientific article published on 21 December 2018

Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes

scientific article published on 17 April 2017

Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus

scientific article published on 06 February 2017

Lipoatrophy in children with type 1 diabetes: an increasing incidence?

scientific article

Lipoatrophy in children, adolescents and adults with insulin pump treatment: is there a beneficial effect of insulin glulisine?

scientific article published on 01 August 2020

Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

scientific article

Long-term Study of Tubeless Insulin Pump Therapy Compared to Multiple Daily Injections in Youth with Type 1 Diabetes: Data from the German/Austrian DPV-Registry

scientific article published on 15 February 2018

MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial

scientific article published on 16 December 2016

Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study

scientific article published on 29 August 2018

Pediatric Diabetes and Skin disease (PeDiSkin): a cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes

scientific article published on 28 September 2020

Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes

scientific article published on 18 January 2016

Pharmacological Properties of Faster-Acting Insulin Aspart

scientific article published on 23 September 2017

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

scientific article

[The Way to Closed Loop - Dream and Reality]

scientific article published on 17 May 2017

List of works by Torben Biester

"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients

Add-on Therapy with Dapagliflozin under Full Closed Loop Control improves Time in Range in Adolescents and young Adults with Type 1 Diabetes- The DAPADream Study

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians

Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes

Blood pressure measurement methodology and technology in the SWEET diabetes centers: An international SWEET database survey

Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict metabolic control: A multicentre analysis of 15 199 adult type 1 diabetes patients from Germany and Austria

Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial. ⬇️

Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care

Comparison of pharmacokinetics and the exposure-response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabete

Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes

Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus

Lipoatrophy in children with type 1 diabetes: an increasing incidence?

Lipoatrophy in children, adolescents and adults with insulin pump treatment: is there a beneficial effect of insulin glulisine?

Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

Long-term Study of Tubeless Insulin Pump Therapy Compared to Multiple Daily Injections in Youth with Type 1 Diabetes: Data from the German/Austrian DPV-Registry

MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial

Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study

Pediatric Diabetes and Skin disease (PeDiSkin): a cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes

Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes

Pharmacological Properties of Faster-Acting Insulin Aspart

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

[The Way to Closed Loop - Dream and Reality]